Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Courtesy of Dr. Carlos Fava.

Pedal Artery Angioplasty: Beneficial in Critical Limb Ischemia

Delaying or failing to heal trophic wounds in critical limb ischemia (CLI) changes quality of life, delays rehabilitation and is associated to infections and amputation.

 

Pedal artery revascularization with angioplasty would speed up recovery and improve CLI wound healing.

 

The study analyzed 257 patients with de novo infrapopliteal lesions receiving PCI for CLI. 140 of these patients (54.5%) received pedal artery angioplasty (PAA).

 

Mean age was 73, all patients were in Rutherford class 5 or 6, and one third of patients presented >3 mg/dl creatinine. There were no differences in type, location depth or infection of trophic wounds.

 

Angiosome direct revascularization was successful in 60.3% of the population. In PAA patients, ankle brachial index (0.88 vs. 0.81; p=0.004) and skin perfusion pressure was higher (49.3 mmHg vs. 41.9 mmHg; p=0.02).

 

At one year follow up, limb salvage was 88.5% and amputation free survival rate was 73.5%. Wound resolution was 49.5%. In the moderate risk group, pedal artery revascularization saw better resolution of trophic wounds and better time to wound healing (59.3% vs. 38.1%; p=0.003 y 211 vs. 365 days; p=0.008).

 

Independent predictors of delayed healing were:

  • non ambulatory status
  • wound depth (UT ≥2)
  • the need for hemodialysis

 

Conclusion

Patients receiving pedal artery angioplasty showed higher trophic wound healing and better time to healing. As regards wound healing, this aggressive strategy could become a salvage procedure for patients with CLI and pedal artery disease.

 

Editorial Comment

Critical Limb Ischemia is on the rise, and in this analysis, a more aggressive angioplasty procedure showed benefits, especially in high risk groups.

 

It is important to have programs for this group of patients and to familiarize with wound classification, depth and infection presence (UT and WIFI classifications) to be able to better assess strategies.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Clinical Outcome of Pedal Artery Angioplasty for Patients with Ischemic Wounds

Results from the Multicenter RENDEZVOUZ Registry.

Reference: Tatsuya Nakama, et al. J Am Coll Cardiol Intv 2017;10:79-90.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...